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Background: This study investigated the household economic burden of eating disorders and cost-related
non-adherence to treatment in Australia.
Methods: Multi-centre prospective observational study using a structured questionnaire. Ninety participants were
recruited from two clinic settings in New South Wales, Australia and from the community using social media. The
primary outcome measures were household economic burden of illness measured in terms of out-of-pocket
expenditure, household economic hardship and cost-related non-adherence.
Results: The pattern of out-of-pocket expenditure varied by diagnosis, with Bulimia Nervosa associated with the
highest total mean expenditure (per three months). Economic hardship was reported in 96.7% of participants and
17.8% reported cost-related non-adherence. Those most likely to report cost-related non-adherence had a longer
time since diagnosis. Cost-related non-adherence and higher out-of-pocket expenditure were associated with
poorer quality of life, a more threatening perception of the impact of the illness and poor self-reported health.
Conclusions: This study is the first to empirically and quantitatively examine the household economic burden of
eating disorders from the patient perspective. Results indicate that households experience a substantial burden
associated with the treatment and management of an eating disorder. This burden may contribute to maintaining
the illness for those who experience cost-related non-adherence and by negatively influencing health outcomes.
Current initiatives to implement sustainable and integrated models of care for eating disorders should strive to
minimise the economic impact of treatment on families.Background
There were estimated to be 914,000 people with eating
disorders in Australia in 2012 [1]. The costs to society in
terms of costs of care, productivity cost and deadweight
loss (foregone productive opportunities to society associ-
ated with higher taxes due to illness) was $69 billion in
2012 [1]. The costs of treatment alone for eating disorders
can pose a substantial economic burden. For example, in
the Australian private hospital sector, the treatment of an
episode of Anorexia is estimated to come second to the
cost of cardiac artery bypass surgery [2]. For individuals, al-
though universal health coverage and social safety nets
exist, significant costs and potential economic hardship are
still experienced by many with chronic and long-term* Correspondence: sjan@georgeinstitute.org.au
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unless otherwise stated.illnesses [3-8]. While direct costs for most health care ser-
vices are either fully or partially subsidised, the limited
availability of specialist services for the treatment and man-
agement of eating disorders in the public hospital system
forces many to seek private treatment. Consequently, sub-
stantial unbudgeted out-of-pocket costs and copayments
can still be faced. In addition to these costs, other eco-
nomic and social consequences are incurred by individuals
and their households, through changes in education, em-
ployment, work participation and social engagement, in-
cluding for family members who provide necessary yet
unpaid informal care [2-9].
When people with chronic illness struggle to pay for
healthcare, cost-related non-adherence with treatment,
particularly prescription medications, occurs [10-12]. Lack
of drug coverage has been found to strongly inhibit pre-
scription drug use, even in Australia where most essential
medications for chronic illnesses are heavily subsidized. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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[11-13]. Such as scheme covers, with a patient copayment,
the cost of listed medicines (through the Pharmaceutical
Benefits Scheme (PBS)) and medical services (through the
Medical Benefit Scheme (MBS)). Exemption from co-
payments is available when individuals hit a certain ‘safety
net’ threshold, which is a defined level of expenditure per
calendar year (in 2014, the PBS threshold is $1421 per
year for general beneficiaries and $360 per year low in-
come concession card holders; for MBS it is $1248 and
$624 respectively per year).
In addition, poor mental health has also been consist-
ently linked to cost-related non-adherence [10]. Given
medications such as antidepressants and antipsychotics
are often used to treat comorbid psychological conditions
of eating disorders such as depression, and anxiety, it is
likely the problem of cost-related non-adherence also ex-
tends to eating disorders. Cost-related non-adherence to
medications and medical care for eating disorders has not
been previously explored in the literature.
There is a shortage of published empirical studies
quantifying the household economic burden of eating
disorders globally, including in the Australian context.
While there are published cost-of-illness studies that
have estimated the societal costs, the emphasis has gen-
erally been on the health system burden and productivity
losses and not the burden faced by individuals and their
families [14,15]. In addition, studies tend to focus on
one illness and so have not provided comparisons across
broad diagnosis groups [16]. Given the stigma associated
with such conditions and other challenges associated
with recruitment, studies also tend to be small, qualita-
tive or based on retrospective analyses of administrative
data. Here we provide a more nuanced examination of
the diverse economic impacts associated with treatment
and management, with a particular focus on the impact
on patients and their families. The aim of this study was
to investigate the household economic burden of eating
disorders in Australia and the relationship between such
burden and health outcomes.
Methods
We recruited English-speaking individuals who received
treatment for any eating disorder in Sydney, Australia at
Wesley Private Hospital and at the outpatient program
at Royal Prince Alfred (RPA) Public Hospital. Given the
challenges of recruiting research participants with an
eating disorder, particularly given the stigma involved in
such illness [17], we used a multifaceted recruitment
strategy. An opt-in invitation and a study questionnaire
were posted to all individuals who received treatment at
Wesley Hospital from January 2009 to March 2011, and
were sent by email with a link to an online version of
the study documents to all individuals who receivedtreatment at RPA Hospital from January 2010 to December
2012. Individuals either self-administered the questionnaire
or completed it with a researcher. The questionnaire was
re-sent, either by post or email to all non-respondents six
weeks after the initial mailing and the remaining non-
respondents at 10 weeks were re-contacted by telephone
with a further reminder. In addition, current patients at
each centre were invited to participate in the study and
either self-administered the study questionnaire or com-
pleted it with the assistance of a researcher.
Recruitment information was also posted on two na-
tional consumer websites: The Centre for Eating and
Dieting Disorders and the Butterfly Foundation and was
posted on the Butterfly Foundation’s Facebook page. In-
terested individuals completed the study questionnaire
over the phone with the assistance of a researcher.
The return of a completed questionnaire by post or
online or completion over the telephone was understood
to imply consent to participate in the study. Participants
who completed the questionnaire in person with the as-
sistance of a researcher provided written informed con-
sent. This study was approved by the following Human
Research Ethics Committees: Western Sydney Local Health
District (2794); University of the Sydney (12623) and
Sydney Local Health District (X12-0145).
The questionnaire was developed based on the au-
thors’ previous work and included questions drawn from
existing standardised tools. It covered the following do-
mains: demographics; medical history; health outcomes;
household economic circumstances and social resources
(i.e. the number and type of social contacts) (Additional
file 1: Table S1).
The primary outcome was the household economic
burden of eating disorders measured using the following:
out-of-pocket expenditure on medical and health-related
expenses, household economic hardship (hardship here-
after) and cost-related non-adherence.
Participants reported out-of-pocket expenditure in the
past three months for: prescription and non-prescription
medications; medical and allied health care; hospitalisa-
tions; medical tests; medically-related transportation;
home and self-care assistance; medical equipment and
supplies; and special food requirements. The burden of
out-of-pocket expenditure, measured as the proportion
of household income spent on illness-related expenses
in the past three months is also reported. Equivalised
household income (income hereafter) was used for this
outcome [18]. It makes adjustments to actual income to
account for households of different size and composition.
Hardship was measured using a series of questions
about financial stress (e.g. failure to pay living and med-
ical expenses) and the use of dissaving actions in the
previous 12 months. Dissaving behaviour is an action
where spending is greater than income thereby reducing
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nance the expenditure [19]. Hardship was a dichotom-
ous variable where a reported inability to pay or the use
of a dissaving action was classed as hardship.
Cost-related non-adherence was measured using the
following questions: In the last 12 months have you: a)
missed a medical appointment due to cost; b) not filled a
prescription due to cost. This was a dichotomous variable
where a ‘Yes’ response to either question was defined as
cost-related non-adherence.
Health outcomes
a) Quality of life, using the EuroQoL questionnaire, a
measure of health-related quality of life [20]. A score
between zero (worst health) and one (best health)
was generated;
b) Self-reported health, using a standard question from
the Short Form 12 survey of health-related quality
of life [21]: How would you rate your health today?
Participants were provided with five discrete response
options. We report the proportion of participants
indicating ‘fair’ or ‘poor health’; and
c) Illness perception, using the Brief Illness Perception
Question (BIPQ), a nine item scale that assesses
cognitive and emotional representations of illness
[22]. A higher score indicates a more threatening
perception of the impact of the illness.
d) Eating Disorders Quality of Life Questionnaire [23]:
The Eating Disorders Quality of Life (EDQOL)
instrument, a disease-specific self-report questionnaire
designed for patients with an eating disorder was also
used to assess quality of life. A score between 0 and 4
is generated for each sub-scale (i.e. Financial; work
and education). The lower the score, the better the
quality of life rating.We conducted descriptive analyses of frequencies for
each component of hardship and calculated means, me-
dians and distributions for total out-of-pocket expend-
iture and for each category of expenditure. Bivariate
analyses, using the chi-square test and the independent
t-test, were used to compare participants with and with-
out cost-related non-adherence for categorical and con-
tinuous variables respectively. Logistic regression was
used to identify the factors that were associated with
cost-related non-adherence, beginning with a saturated
model that included all explanatory variables that were
associated with the outcome (P <0.25) in the univariate
analysis (see Additional file 1: Table S2). Variables were
assessed individually for significant contribution to the
overall model (P < 0.05). Effect modification was checked
between variables in the model to identify significant inter-
actions (P < 0.01). The Hosmer and Lemeshow goodness-of-fit test was used to check the fit of the final model.
In addition, the analysis of variance test was used to
analyse the relationship between the economic out-
comes and health outcomes. Data analysis was con-
ducted using SPSS 21.
Results
Characteristics of the study population
Figure 1 shows the flow of participants into the study.
Ninety participants completed questionnaires. 54.4% of
participants had a self-reported diagnosis of Anorexia
Nervosa (AN), either purging or restricting subtype,
16.7% had a diagnosis of Bulimia Nervosa (BN) and
28.9% were diagnosed as either Binge Eating Disorder,
Eating Disorder Not Otherwise Specified or did not know
their diagnosis (Other hereafter) (Table 1). Although sex
was not a basis for exclusion, 99% of respondents were fe-
male (Table 1). Participants recruited from Wesley Hos-
pital were more likely to have the following characteristics:
a diagnosis of AN, a hospital admission in the previous
12 months, qualified for the Medicare or Pharmaceutical
Benefits Scheme safety net programs at the time of the
interview, private health insurance and were less likely to
be in paid employment. Participants were similar in all
other characteristics.
Household economic outcomes
96.7% of participants reported experiencing hardship in
the previous 12 months and this proportion was similar
across diagnosis groups (Table 2). Paying for medical ap-
pointments was the most commonly reported source of
financial stress (44.3%), followed by dental appointments
(31.0%), utility bills (29.5%), medications (25.3%) and
food (25.0%). Using savings that had been put aside for
other purposes (61.4%) and seeking assistance from
friends and family (45.3%) were the most commonly re-
ported strategies used when faced with financial stress.
17.8% of participants reported cost-related non-adherence
and this was more common among those with a diagnosis
of AN (20.4%) or BN (20.0%) compared to those with a
diagnosis otherwise classified (11.5%).
Participants with a BN diagnosis reported spending
double the amount out-of-pocket in the previous three
months compared to those with an AN diagnosis (BN:
AUD$3175 versus AN: AUD$1525) and this was consist-
ent for most expenditure categories (Figure 2). The main
expenditure categories for all participants were hospitalisa-
tions (AN: AUD$580; BN: AUD$977; Other: AUD$255),
psychologist and counsellor appointments (AN: AUD$456;
BN: AUD$691; Other: AUD$600), specialist appointments
(AN: AUD$243; BN: AUD$304; Other: AUD$249) and
medications (AN: AUD$300; BN: AUD$222; Other: AUD
$123). At these levels of expenditure, households spent a
mean of 20.7% (SD:33.2; median: 7.5, IQR:17.1) of income
Figure 1 Study flow chart.
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month period. The burden of out-of-pocket expend-
iture was highest among those with BN (AN:22.9%
(SD:33.8); BN:35.6% (SD:48.1); Other: 7.4% (SD:8.3);
F = 3.3, P = 0.04).
Determinants of cost-related non-adherence
Table 3 summarises the determinants of cost-related
non-adherence in the past 12 months (see Additional file
1: Table S2 for the univariate results). The time since
diagnosis was the only significant determinant, indicat-
ing that for every additional year since diagnosis with an
eating disorder, participants were 1.15 times more likely
to report cost-related non-adherence (95% CI: 1.02-1.30,
P = 0.02).
Relationship between economic and health outcomes
For both economic outcomes, there was a negative rela-
tionship with quality of life, participants’ perceptions of
the impact of the illness and self-reported health. Each
health outcome worsened with higher out-of-pocket ex-
penditure and poorer health outcomes were reported by
those with cost-related non-adherence (Table 4).
Discussion
To the authors’ knowledge, this is the only study to
comprehensively and quantitatively examine the house-
hold economic burden associated with eating disorders
across multiple sites. We found high rates of hardship,
high out-of-pocket expenditure and a high out-of-pocket
cost burden in the study population. 97% of participants
reported at least one incident of hardship in the previous
12 months. Over 40% of participants spent greater than
10% of their household income on illness-related costs, a
level of expenditure that has been defined as ‘catastrophic’in other studies [24,25]. In comparison, in other chronic
disease populations in Australia, only 12% and 5% of the
study population spent greater than 10% and 20% of their
income respectively on illness-related costs [26]. The im-
pacts of this burden were reinforced by the other outcome
measures, with cost-related non-adherence reported by
18% of participants and the finding of poorer health out-
comes among those experiencing a great economic burden.
Unlike other chronic conditions, the model of care for
managing eating disorders in Australia largely sits out-
side of the primary health care setting and includes a
mix of specialist eating disorder programs, most of
which are offered in private settings. Other than through
admission to hospital for acute treatment for severe epi-
sodes, the availability of treatment through the public
system is limited. Private health insurance policies gen-
erally pay for inpatient care but coverage is variable for
services provided in an outpatient or day program set-
ting. A consequence of this, as found in this study, is
that patients who access outpatient care as opposed to
those admitted as inpatients tend to experience a greater
burden.
The Australian National Framework for Eating Disor-
ders has called for the development of a sustainable and
integrated service model and as part of this, a review of
Medicare items and private health insurance funding to
ensure that the current financing models better support
the diverse continuums of care required by patients with
different eating disorders [9]. In light of the findings of
this study, this would also help to ensure access to opti-
mal and potentially cost-effective care and help ensure
that the current models of care do not continue to
undermine the equity objectives of the Australian health
care system by creating disparities in access, utilisation
and economic burden.
Table 1 Characteristics of the study population overall and by recruitment sitea
Personal and family information Total Private Hospital Public Hospital
(n = 90) (n = 67) (n = 18)
Age, mean (±SD) 24.5 (SD = 8.3) 28.9 (SD:8.7) 27.3 (SD:6.9)
Female 89 /90 (98.9%) 66 (98.5%) 18 (100%)
English spoken at home 81/90 (90.0%) 60 (89.6%) 17 (94.4%)
Marital status
Couple 21/89 (23.6%) 15 (22.4%) 6 (33.3%)
Single 68/89 (76.4%) 52 (77.6%) 12 (66.7%)
Current living situation
Living with parents 42/90 (46.7%) 33 (49.3%) 7 (38.9%)
Living with spouse/partner 21/90 (23.3%) 16 (23.9%) 5 (27.8%)
Living alone 14/90 (15.6%) 10 (14.9%) 2 (11.1%)
Living in shared accommodation 12/90 (14.4%) 8 (11.9%) 4 (22.2%)
Highest qualification completed or in the process of completing
Secondary school or lower 19/89 (21.3%) 16 (23.9%) 3 (16.7%)
University or TAFE 70/89 (78.7%) 51 (76.1%) 14 (77.8%)
Current work statusb
Employed (full or part-time) 42/90 (46.7%) 30 (44.8%) 10 (55.6%)
Employed, on sick leave 7/90 (7.8%) 3 (4.5%) 3 (16.7%)
Unemployed 6/90 (6.7%) 4 (6.0%) 2 (11.1%)
Unemployed, due to medical reasons 22/90 (24.4%) 20 (29.9%) 0
Other 13/90 (14.4%) 10 (14.9%) 2 (11.1%)
Medical information
Age when eating disorder was diagnosed, mean (±SD) 18.0 (SD = 4.9) 17.6 (SD:4.8) 19.9 (SD:5.1)
Years since diagnosis, mean (±SD) 10.6 (SD = 8.3) 11.2 (SD:8.6) 7.8 (SD:6.6)
BMI, mean (±SD) 19.4 (SD = 3.9) 19.1 (SD:4.2) 20.1 (SD:2.7)
Eating disorder diagnosis, by broad categoryb,c
Anorexia Nervosa 49/90 (54.4%) 45 (67.2%) 2 (11.1%)
Bulimia Nervosa 15/90 (16.7%) 11 (16.4%) 2 (11.1%)
Other 26/90 (28.9%) 11 (16.4%) 14 (77.8%)
Psychological co-morbidity
Alcohol and/or substance abuse 16/88 (18.2%) 13 (19.7%) 2 (11.1%)
Anxiety disorders 50/88 (56.8%) 41 (62.1%) 7 (41.2%)
Bi-polar disorder 4/88 (4.5%) 3 (4.5%) 1 (5.9%)
Depression 77/88 (87.5%) 60 (90.9%) 14 (82.4%)
Psychosis 4/88 (4.5%) 3 (4.5%) 1 (5.9%)
Proportion with a hospital admission for the treatment of the eating disorder
or associated complications in the past 12 months?b
50/89 (56.2%) 43 (64.2%) 4 (23.5%)
Insurance status
Reached the Pharmaceutical Benefits Scheme (PBS) safety net thresholdb 15/89 (16.9%) 15 (22.4%) 0
Reached the Medicare safety net thresholdb 31/89 (34.8%) 28 (41.8%) 2 (11.8%)
Private health insuranceb 78/89 (86.7%) 63 (94.0%) 12 (70.6%)
Income
AUD$20,000 and under 9/89 (10.1%) 6 (9.0%) 1 (5.9%)
AUD$20,000-39,999 19/89 (21.3%) 16 (23.9%) 3 (17.6%)
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Table 1 Characteristics of the study population overall and by recruitment sitea (Continued)
AUD$40,000-59,999 7/89 (7.9%) 4 (6.0%) 3 (17.6%)
AUD$60,000-79,999 7/89 (7.9%) 4 (6.4%) 1 (5.9%)
AUD$80,000-99,999 7/89 (7.9%) 4 (6.4%) 3 (17.6%)
AUD$100,000 or more 22/89 (24.4%) 20 (29.9%) 1 (5.9%)
Don’t know/rather not answer 18/89 (20.2%) 13 (19.4%) 5 (29.4%)
Data are shown as frequency and proportion (%) or mean and standard deviation (±SD).
aData are not shown separately for the subsample who were recruited online as n = 5.
bWe found a significant difference in these variables by recruitment site, P < 0.05.
cAnorexia includes: Anorexia nervosa purging subtype and restricting subtype; Other includes: Binge Eating Disorder, Eating Disorder Not Otherwise Specified and
Don’t know / not sure.
Table 2 Summary of household economic outcomes in the study population
Overall Anorexia Nervosa Bulimia Nervosa Other
n = 90 n = 49 n = 15 n = 26
Household economic outcomes n % n % n % n %
Economic hardship 87 96.7% 48 98.0% 14 93.3% 25 96.2%
Could not pay for
Utilities 26 29.5% 14 29.2% 4 26.7% 8 32.0%
Rent/mortgage 14 15.9% 8 16.7% 3 20.0% 3 12.0%
Car payments 19 21.6% 13 27.1% 1 6.7% 5 20.0%
Minimum credit card payment 19 21.6% 12 25.0% 2 13.3% 5 20.0%
Medications 22 25.3% 15 31.3% 3 20.0% 4 16.7%
Medical/health appointments 39 44.3% 22 45.8% 5 33.3% 12 48.0%
Health insurance 13 14.9% 7 14.9% 2 13.3% 4 16.0%
Dental appointments 27 31.0% 17 36.2% 2 13.3% 8 32.0%
Transport 14 16.3% 10 21.7% 1 6.7% 3 12.0%
Food 22 25.0% 13 27.1% 4 36.7% 5 20.0%
Did not attend medical appointments 30 34.5% 16 34.0% 5 33.3% 9 36.0%
Did not fill prescriptions 23 26.1% 15 31.3% 4 26.7% 4 16.0%
Unable to heat home 13 14.8% 8 16.7% 2 13.3% 3 12.0%
Did you do use any of these strategies because
you were short on money?
Reduced home loan payments 5 5.7% 1 2.1% 2 13.3% 2 8.0%
Used savings put aside for other purposes 54 61.4% 30 62.5% 8 53.3% 16 64.0%
Moved house 13 14.9% 8 17.0% 4 26.7% 1 4.0%
Increased credit card debt $1000 or more 26 29.9% 13 27.7% 4 26.7% 9 36.0%
Sought financial assistance from friends/family 39 45.3% 21 45.7% 8 53.3% 10 40.0%
Sought financial assistance from welfare or
community organisation
20 23.0% 12 25.5% 3 20.0% 5 20.0%
Informal loan 14 16.1% 7 14.9% 3 20.0% 4 16.0%
Formal loan 9 10.3% 5 10.6% 1 6.7% 3 12.0%
Sold assets 13 14.9% 4 8.5% 4 26.7% 5 20.0%
Other 16 18.4% 10 21.3% 2 13.3% 4 16.0%
Cost-related non-adherence 16 17.8% 10 20.4% 3 20.0% 3 11.5%
Spent greater than 10% of income on medical
and health-related expenses (self-reported)
30 41.7% 17 44.7% 6 46.2% 7 33.3%
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Figure 2 Out-of-pocket cost for 3 months by disease and expenditure category.




Characteristics OR (95% CI) P-Value OR, 95% CI P-Value
Time since
diagnosis (years)
1.05 (0.99-1.11) 0.092 1.15 (1.01-1.31) 0.04
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the amount and composition of out-of-pocket expend-
iture would vary by diagnosis. This is likely a function of
the differences between the disorders, which may require
different models of treatment. For example, the majority
of the sample had private health insurance with hospital
coverage. Patients with AN are more likely than patients
with other eating disorders to require lengthy inpatient
admissions to recover weight. As a public patient in a
public hospital this would be free of charge, as a private
patient a significant portion of treatment costs would
nonetheless be covered by private health insurance.
However, those with BN generally undergo outpatient
treatment or receive care in day programs, for which the
coverage of services by private health insurers can be
variable. This coupled with transport costs to receive
this treatment may provide some explanation as to why
patients with BN had significantly higher out-of-pocket
expenditures.
Cost-related non-adherence found in this study popula-
tion suggests that the household economic burden associ-
ated with eating disorders may contribute to maintaining
the illness by preventing participation in ongoing treat-





Characteristic OR (95% CI) P-Value OR (95% CI) P-Value
Time since
diagnosis (years)






1.59 (1.08–2.35) 0.02 1.44 (0.98–2.11) 0.06
Quality of life
(EQ-5D)
0.08 (0.005–1.13) 0.06 0.30 (0–6.24) 0.20
aThe adjusted model was built using backward selection of all variables associated
with the outcome variable at the level of P <0.25 in univariate analysis
(See Additional file 1: Table S2). Hosmer and Lemeshow goodness-of-fit test:
χ2: 6.12, p = 0.63.services available to patients. For example, within Australia’s
public system, Medicare’s Better Access Initiative provides
rebates for up to 10 visits per calendar year with an allied
mental health service (e.g. psychologist), which falls short
of the recommended guidelines of 40 visits for patients
with AN and 20 visits for those with BN [27]. In this
study, participants reported spending an average of AUD
$535 out-of-pocket (in the past 3 months) on psychologist
appointments. Given the high prevalence of psychological
comorbidities [16] and moderate rates of full recovery ex-
perienced by patients with an eating disorder [28-30], the
development of strategies to minimise cost-related non-
adherence may help to break the cycle in which the eco-
nomic burden of illness on households prevents optimal
















No 0.12 (0.021-0.62) 0.059 (0.004-0.90)
Don’t know 0.46 (0.16-1.32) 1.23 (0.23-6.46)
aThe adjusted model was built using backward selection of all variables
associated with the outcome variable at the level of P <0.25 in univariate analysis
(See Additional file 1: Table S2). Hosmer and Lemeshow goodness-of-fit test:
χ2:6.40, p = 0.60.
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the study’s limitations. First, this study was conducted
with a mostly urban dwelling population who had re-
ceived treatment on at least one previous occasion. In
the absence of other empirical and quantitative data, this
study provides important insights into the cost-pressures
associated with treatment of an eating disorder. However,
it is likely that individuals residing in rural and remote set-
tings face additional economic barriers associated with
accessing care as most specialist services are provided in
urban settings in Australia. We have also missed individ-
uals who have forgone treatment, either due to cost or
other reasons (e.g. stigma). Because the sample is not
likely to be representative, it was not possible to derive
generalisable estimates of the prevalence of economic
hardship outcomes in this study. The focus was on the
factors that were associated with this set of outcomes.
Second, 29% of the sample indicated a diagnosis ‘not
otherwise specified’. Given the likely heterogeneity in
this subgroup, it is also not possible to generalise from
the findings of this subgroup. Third, despite using a
multidimensional recruitment strategy, this study had a
low participation rate. This is not uncommon in studies
in eating disorder populations [17] however, we cannot
rule out the possibility that this study may be under-
represented by those with poorer outcomes who may
be less likely to participate in research. Fourth, the out-
comes were measured at one point in time so it is not
possible to ascertain with certainty the direction of re-
lationships reported. Longitudinal research in a larger
representative sample of patients will help to elucidate
the determinants and potential ameliorating factors of
this burden.
This study has shown that hardship may be a disease
maintaining factor as people may fail to seek the neces-
sary care for economic reasons and this can impact on
health outcomes. A better understanding of the factors
underlying hardship has the potential to break this cycle.Conclusions
This research raises important policy implications. The
current models of funding for the treatment of eating
disorders do not encourage management of patients in
the community or in outpatient settings because the
public system offers limited treatment options beyond
admission for severe, acute episodes. Private health in-
surance tends to provide only limited reimbursement
outside private hospital admission. This pattern of fund-
ing discourages upstream management of illness, does
little to prevent exacerbation of illnesses and leads to a
model of care based on high cost acute management.
This inevitably creates inequities in access to treatment
based on socioeconomic status, access to health insuranceand type of condition. This research underscores the need
for more sustainable and affordable treatment models
within the public and private systems to not only improve
health outcomes, but to mitigate the substantial house-
hold economic burden experienced by patients undergo-
ing care.
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